FDA OKs First ‘Digital Pill’ That Lets Doctors Know It’s Been Taken

The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or “mixed” episodes for people with bipolar disorder.

The resource:27






Leave a Reply

Your email address will not be published. Required fields are marked as *

*

This blog is kept spam free by WP-SpamFree.